Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MRNA compared with NVAX: revenue, margins and what each company keeps, and the suppliers and customers both name
MRNA
Moderna, Inc.
Change
Mkt cap
Revenue
Revenue
NVAX
Novavax Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MRNA
Moderna, Inc.
vs
NVAX
Novavax Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MRNA, solid
NVAX, dashed
MRNA
Moderna, Inc.
Change
220.15
▼
−0.71%
· post 220.50
Mkt cap
$88.5B
Revenue
$145M
Q2 FY26
Revenue
$1.9B
FY25
NVAX
Novavax Inc
Change
9.51
▼
−5.65%
· post 9.53
Closed
Nov 2 '26
Mkt cap
$1.7B
Revenue
$57M
Q2 FY26
Revenue
$1.1B
FY25
vs
Compare
Closed
Nov 2 '26
MRNA
Moderna, Inc.
vs
NVAX
Novavax Inc
220.15
▼
−0.71%
post 220.50
Price
9.51
▼
−5.65%
post 9.53
$88.5B
Mkt cap
$1.7B
Q2 FY26
$145M
Revenue
$57M
Q2 FY26
FY25
$1.9B
Revenue
$1.1B
FY25
Change
Change
MRNA
220.15
▼
−0.71%
vs
NVAX
9.51
▼
−5.65%
Closed
Nov 2 '26